For years, teachers and parents at a Liberty, Missouri, elementary school have worried that something in and around their ...

On Monday, actress Lyndie Greenwood shared that she was diagnosed with invasive ductal carcinoma in September 2024, and ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Pfizer paid a whopping $1 billion upfront for rights to vepdegestrant (formerly ARV-4710 in 2021 – consisting of $650 million ...

Dr. Alison Moody, a breast surgeon at Ascension Sacred Heart in Panama City, shares her advice on how to interpret the Jan. 3 ...

In her blog, Greenwood explained that on September 12, 2024, she was diagnosed with invasive ductal carcinoma — a type of ...

Of these, more than 4.5 lakh treatments worth over Rs 985 crore were undertaken for "targeted therapies" against cancer, with ...

Certain foods and habits can impact your chances of getting cancer in your lifetime. Here, we share the latest research as ...

Advocates argue that out-of-pocket costs for additional imaging, such as MRIs or diagnostic mammograms, deter patients from seeking necessary follow-up exams.

Vepdegestrant did not improve progression-free survival broadly but saw improvements in one specific patient cohort. Arvinas’ ...